Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Brissot, Eolia  [Clear All Filters]
2014
Brissot, E., Labopin, M., Beckers, M.M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G.J., et al. (2014). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Haematologica.
2015
Peric, Z., Cahu, X., Malard, F., Brissot, E., Chevallier, P., Guillaume, T., Gregoire, M., Gaugler, B., and Mohty, M. (2015). Peripheral blood plasmacytoid dendritic cells at day 100 can predict outcome after allogeneic stem cell transplantation.Biol Blood Marrow Transplant.
2016
Giebel, S., Czyż, A., Ottmann, O., Baron, F., Brissot, E., Ciceri, F., Cornelissen, J.J., Esteve, J., Gorin, N.-C., Savani, B., et al. (2016). Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the acute leukemia working party of the .Cancer.
2019
Stocker, N., Duléry, R., Battipaglia, G., Brissot, E., Médiavilla, C., Sestili, S., Paviglianiti, A., Ledraa, T., Mohty, R., Bazarbachi, A., et al. (2019). Impact of Cyclosporine-A Concentration on Acute Graft-versus-Host Disease Incidence after Haploidentical Hematopoietic Cell Transplantation.Eur J Haematol.
Mohty, R., Brissot, E., Battipaglia, G., Ruggeri, A., Duléry, R., Bonnin, A., Médiavilla, C., Sestili, S., Belhocine, R., Vekhoff, A., et al. (2019). Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation.Br J Haematol.
2020
Bazarbachi, A., Labopin, M., Angelucci, E., Gulbas, Z., Ozdoğu, H., Arat, M., de Rosa, L., Pastano, R., Pioltelli, P., Montserrat, R., et al. (2020). Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party.Biol Blood Marrow Transplant.